MDMA-Assisted Therapy

The FDA has designated MDMA-Assisted Therapy for PTSD a Breakthrough Therapy.

What is MDMA-Assisted Therapy?

MDMA-Assisted Therapy combines regulated doses of MDMA with psychotherapy to enhance the therapeutic process and help people reach memories, emotions, and insights that are not easily accessible. 

The Multidisciplinary Association for Psychedelic Studies (MAPS) final Phase 3 MDMA-assisted therapy trial investigating the treatment of moderate to severe Post-Traumatic Stress Disorder (PTSD), showed promising results. 71.2% of participants who received MDMA-Assisted Therapy no longer met the criteria for PTSD, by the end of the study.

MDMA-Assisted Therapy is not currently an approved treatment, however, with the completion of the MAPS clinical trials, the next step will be an application for FDA approval.

What does it treat?

Clinical trial results indicate that MDMA-Assisted Therapy could be a promising treatment for Post-Traumatic Stress Disorder (PTSD).

In the event of an emergency, it’s crucial to seek help as soon as possible. The National Suicide Prevention Lifeline, also known as the 988 Suicide & Crisis Lifeline, is available 24/7 to provide support and resources.

You can access this service by dialing 988 or by calling 1-800-273-8255.

In the case of an immediate danger to yourself or others, calling 911 should be your first course of action.

How Does It Work?

MDMA has profound impacts on state of consciousness, creating empathy and openness that many people find to be a positive experience. MDMA can alter one’s perceptions and reduce feelings of depression, anxiety, and fear. Research suggests that by reducing fear and defensiveness, both of which are feelings often present in PTSD, MDMA can create a psychological state that is uniquely positioned to support long-term psychological healing from trauma.


Learn More About MDMA-Assisted Therapy


Psychedelics are an emerging area of medicine. Information on this page is presented for educational purposes only and is not an exhaustive summary of the current state of research relative to psychedelic treatments, their reliability, contraindications, risks, side effects, or other pertinent information. Other than Spravato,® a form of esketamine, psychedelic medications have not been approved by Health Canada or the Food and Drug Administration for any mental health indication. Please refer to our Educational and Opinion Disclaimer.


Stay up to date by subscribing to the Numinus Newsletter.
By signing up you consent to the Privacy Policy & Terms of Use.
Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram